Wambolt & Associates’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $3.95M | Sell |
20,771
-1,569
| -7% | -$298K | 1.33% | 20 |
|
2025
Q1 | $4.61M | Sell |
22,340
-1,582
| -7% | -$326K | 1.56% | 15 |
|
2024
Q4 | $4.25M | Sell |
23,922
-5,138
| -18% | -$913K | 1.36% | 19 |
|
2024
Q3 | $5.72M | Buy |
29,060
+565
| +2% | +$111K | 1.56% | 12 |
|
2024
Q2 | $4.85M | Buy |
28,495
+948
| +3% | +$162K | 1.41% | 13 |
|
2024
Q1 | $4.98M | Buy |
27,547
+97
| +0.4% | +$17.5K | 1.49% | 12 |
|
2023
Q4 | $4.25M | Buy |
27,450
+397
| +1% | +$61.5K | 1.39% | 9 |
|
2023
Q3 | $4.01M | Buy |
27,053
+640
| +2% | +$94.9K | 1.46% | 5 |
|
2023
Q2 | $3.56M | Sell |
26,413
-50
| -0.2% | -$6.74K | 1.27% | 6 |
|
2023
Q1 | $4.25M | Buy |
26,463
+579
| +2% | +$92.9K | 1.51% | 6 |
|
2022
Q4 | $4.18M | Buy |
25,884
+386
| +2% | +$62.4K | 1.61% | 6 |
|
2022
Q3 | $3.42M | Buy |
25,498
+97
| +0.4% | +$13K | 1.45% | 7 |
|
2022
Q2 | $3.89M | Buy |
25,401
+742
| +3% | +$114K | 1.56% | 7 |
|
2022
Q1 | $4.01M | Buy |
24,659
+1,522
| +7% | +$248K | 1.46% | 7 |
|
2021
Q4 | $3.13M | Buy |
23,137
+1,074
| +5% | +$145K | 1.13% | 13 |
|
2021
Q3 | $2.41M | Buy |
22,063
+2,055
| +10% | +$224K | 0.97% | 18 |
|
2021
Q2 | $2.29M | Buy |
20,008
+2,346
| +13% | +$268K | 0.97% | 19 |
|
2021
Q1 | $1.92M | Buy |
17,662
+2,697
| +18% | +$293K | 1% | 19 |
|
2020
Q4 | $1.6M | Buy |
14,965
+2,194
| +17% | +$235K | 0.96% | 21 |
|
2020
Q3 | $1.12M | Buy |
12,771
+2,669
| +26% | +$234K | 0.84% | 30 |
|
2020
Q2 | $992K | Buy |
10,102
+1,860
| +23% | +$183K | 0.78% | 36 |
|
2020
Q1 | $628K | Buy |
8,242
+2,566
| +45% | +$196K | 0.65% | 51 |
|
2019
Q4 | $503K | Sell |
5,676
-2
| -0% | -$177 | 0.38% | 85 |
|
2019
Q3 | $430K | Sell |
5,678
-225
| -4% | -$17K | 0.36% | 97 |
|
2019
Q2 | $429K | Buy |
5,903
+917
| +18% | +$66.6K | 0.36% | 91 |
|
2019
Q1 | $412K | Sell |
4,986
-143
| -3% | -$11.8K | 0.37% | 87 |
|
2018
Q4 | $473K | Buy |
+5,129
| New | +$473K | 0.52% | 61 |
|